Metraipolis › archive › dc_913bf76fac8b

Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China — Europe PMC PMID:42646704

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42646704
DOI
10.3390/vaccines14080687
License (as archived)
solo-consultazione
Archived
2026-10-08T10:35:29.689Z
SHA-256 of the archived text
8cf2c8dd92845c496d832e1bac1e54872a6a5723f824c57de29ba0c0e235318f
Stable URL of this page
https://metraipolis.com/documento/dc_913bf76fac8b

How to cite

Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China — Europe PMC PMID:42646704 — Europe PMC (en), https://europepmc.org/article/MED/42646704 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_913bf76fac8b (Metraipolis archive dc_913bf76fac8b, sha256 8cf2c8dd92845c496d832e1bac1e54872a6a5723f824c57de29ba0c0e235318f)
BibTeX
@misc{dc913bf76fac8b,
  title = {Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China — Europe PMC PMID:42646704},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42646704},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_913bf76fac8b; sha256 8cf2c8dd92845c496d832e1bac1e54872a6a5723f824c57de29ba0c0e235318f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42646704. Agents can read the archived copy with the MCP tool read_document.